Français
ItalianoBond Teva Pharmaceutical Industries 2.25% ( US88166HAD98 ) in USD
| Issuer | Teva Pharmaceutical Industries | ||||||
| Market price | 97.00 % ⇌ | ||||||
| Country |  Israel
|
||||||
| ISIN code |
 US88166HAD98 ( in USD )
|
||||||
| Interest rate | 2.25% per year ( payment 2 times a year) | ||||||
| Maturity | 18/03/2020 - Bond has expired | ||||||
|
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 700 000 000 USD | ||||||
| Cusip | 88166HAD9 | ||||||
| Standard & Poor's ( S&P ) rating | N/A | ||||||
| Moody's rating | N/A | ||||||
| Detailed description |
Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health. The Bond issued by Teva Pharmaceutical Industries ( Israel ) , in USD, with the ISIN code US88166HAD98, pays a coupon of 2.25% per year. The coupons are paid 2 times per year and the Bond maturity is 18/03/2020 |
||||||
| |||||||
